Sign In
close X
The user name and password you entered does not match
the information we have on file.
Forgot your password?
Contact us
close X
Please enter a valid code.
Contact us
Home
|
Texts
|
Drugs
|
Images
|
Guidelines
|
Patient Education
Showing Results for
urinary tract toxicity
Narrow Results
Topics
All Topics (4)
Diagnosis/Workup (1)
Staging and Prognosis (1)
Treatment (1)
radiation exposure and (1)
symptoms and signs (1)
Content Types
All (4)
Texts (4)
NCI Clinical Trials
Looking for trials?
Go to NCI and browse 8,000+ trials
4
Search Results
Human Radiation Injury
Chapter 32. Urinary Function >
Pathophysiology of Radiation Injury
Studies of radiation-induced bladder injury in animal models have been essential in expanding our knowledge on the pathophysiology of radiation injury. Various techniques, including measurement of urinary frequency, bladder compliance, ...
Human Radiation Injury
Chapter 32. Urinary Function >
Clinical Manifestation of Radiation Injury
The clinical manifestation of radiation to the lower urinary tract can be categorized into acute and late reactions. Acute reactions occur during and up to 3 months after radiation exposure. ...
Human Radiation Injury
Chapter 32. Urinary Function >
Scoring Systems
Several validated scoring systems have been proposed to rate bladder toxicity. Acute and late toxicity can be assessed in a variety of ways: symptomatically, radiographically, cystoscopically, cystometrically, and histologically. The ...
Human Radiation Injury
Chapter 32. Urinary Function >
Management of Acute and Late Toxicity
As described above, acute radiation-induced symptoms, such as frequency, hematuria, and/or dysuria, are secondary to irritation and inflammation of the urothelium and bladder smooth muscle. Such symptoms typically resolve within ...
Didn't find what you were looking for?
Run a full-text search on 'urinary tract toxicity'
What do you think of LWWOncology?
Share Your Feedback
More Results
Journal Results from PubMed
Phase I trials of molecularly targeted agents: should we pay more attention to late toxicities?
J. Clin. Oncol. | May 2, 2011
Histopathological features of the kidney after acute renal failure from melamine.
N. Engl. J. Med. | Feb 18, 2010
Long-term evaluation of Ifosfamide-related nephrotoxicity in children.
J. Clin. Oncol. | Nov 9, 2009
Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951).
J. Clin. Oncol. | Jun 17, 2005
Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a phase II Hoosier Oncology Group study.
J. Clin. Oncol. | Feb 18, 2005
View More on PubMed
>